133 related articles for article (PubMed ID: 32168102)
1. The onjisaponin B metabolite tenuifolin ameliorates dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Peng F; Lu L; Wei F; Wu D; Wang K; Tang J
Neuroreport; 2020 Apr; 31(6):456-465. PubMed ID: 32168102
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
3. Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice.
Costa T; Fernandez-Villalba E; Izura V; Lucas-Ochoa AM; Menezes-Filho NJ; Santana RC; de Oliveira MD; Araújo FM; Estrada C; Silva V; Costa SL; Herrero MT
J Neuroimmune Pharmacol; 2021 Jun; 16(2):390-402. PubMed ID: 32564332
[TBL] [Abstract][Full Text] [Related]
4. Imperatorin inhibits oxidative stress injury and neuroinflammation via the PI3K/AKT signaling pathway in the MPTP-induced Parkinson's disease mouse.
Liu L; Jiang L; Zhang J; Ma Y; Wan M; Hu X; Yang L
Neuroreport; 2024 Feb; 35(3):175-184. PubMed ID: 38305108
[TBL] [Abstract][Full Text] [Related]
5. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model.
Zhang Y; Qin L; Xie J; Li J; Wang C
Life Sci; 2020 Jul; 253():117745. PubMed ID: 32376269
[TBL] [Abstract][Full Text] [Related]
6. Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model.
Birla H; Rai SN; Singh SS; Zahra W; Rawat A; Tiwari N; Singh RK; Pathak A; Singh SP
Neuromolecular Med; 2019 Mar; 21(1):42-53. PubMed ID: 30644041
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.
Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
Drug Des Devel Ther; 2015; 9():5499-510. PubMed ID: 26504373
[TBL] [Abstract][Full Text] [Related]
8. FTY720 Inhibits MPP
Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
[TBL] [Abstract][Full Text] [Related]
9. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
[TBL] [Abstract][Full Text] [Related]
10. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP-induced Parkinson's disease.
Haga H; Matsuo K; Yabuki Y; Zhang C; Han F; Fukunaga K
Neurochem Int; 2019 Oct; 129():104492. PubMed ID: 31229554
[TBL] [Abstract][Full Text] [Related]
12. Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice.
Sun L; Xu S; Zhou M; Wang C; Wu Y; Chan P
Brain Res; 2010 Jun; 1335():74-82. PubMed ID: 20380823
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.
Javed H; Azimullah S; Abul Khair SB; Ojha S; Haque ME
BMC Neurosci; 2016 Aug; 17(1):58. PubMed ID: 27549180
[TBL] [Abstract][Full Text] [Related]
14. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.
Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS
J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839
[TBL] [Abstract][Full Text] [Related]
15. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.
Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ
Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson's disease model.
Qiu X; Wang Q; Hou L; Zhang C; Wang Q; Zhao X
Toxicol Lett; 2021 Oct; 349():1-11. PubMed ID: 34052309
[TBL] [Abstract][Full Text] [Related]
17. Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice.
Wang L; Zhai YQ; Xu LL; Qiao C; Sun XL; Ding JH; Lu M; Hu G
Exp Neurol; 2014 Jan; 251():22-9. PubMed ID: 24220636
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.
Moon M; Kim HG; Hwang L; Seo JH; Kim S; Hwang S; Kim S; Lee D; Chung H; Oh MS; Lee KT; Park S
Neurotox Res; 2009 May; 15(4):332-47. PubMed ID: 19384567
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice.
Shi X; Chen YH; Liu H; Qu HD
Mol Med Rep; 2016 Sep; 14(3):2397-404. PubMed ID: 27484986
[TBL] [Abstract][Full Text] [Related]
20. N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP
Luo D; Zhao J; Cheng Y; Lee SM; Rong J
Mol Neurobiol; 2018 Mar; 55(3):2258-2267. PubMed ID: 28321769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
